News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$SQL: Now $1.80 !!!!!!!!!!!!!!!!!!!
BOOoooooooommmmmmmmmm.............. Gave it to you earlier when it just went
over $1.
Look at it nowwwwwwwwwwwwwwwwwww !!!!!!!!!
Where my followers at......... if you like these kinda RIPPPERS, hook me up with a Sub !
I won't be able to let you know how to find these winners otherwise.
GO $SQL
|
Followers
|
1
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
57
|
|
Created
|
11/09/21
|
Type
|
Free
|
| Moderators | |||
SeqLL was founded in 2013 to bring a new breed of next generation sequencing (NGS) technology, True Single Molecule Sequencing (tSMS), to the research and healthcare communities. By bringing together top-level scientists and engineers with extensive expertise in tSMS technology, SeqLL is uniquely positioned to address gaps left by standard sequencing technologies in RNA transcriptome analysis, specialty DNA analysis & beyond.
SeqLL Inc. (SeqLL) is a life sciences instrumentation and research services company that is engaged in the development of scientific assets and novel intellectual property across multiple omics fields. The Company offers ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) sequencing solutions. It uses its true single molecule sequencing (tSMS) technology. SeqLL offers RNA and specialty DNA sequencing services utilizing tSMS. SeqLL offers a range of RNA sequencing services, including its direct RNA sequencing without conversion to complementary DNA (cDNA). The Company operates in a single business segment that includes the design, development and manufacturing of genetic analysis technologies. The Company's testing services are fully customizable to customers research needs and challenges. Its SeqLL technology is used for various application, such as life sciences research and development, liquid biopsy, clinical diagnostics and microbiome analysis.
| Shares Outstanding | 11.7M |
| Float | 1.78M |
| % Held by Insiders | 37.35% |
